Chartwell Investment Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $8.82M | Sell |
|
|||||
|
2021
Q3 | $9.84M | Sell |
|
|||||
|
2021
Q2 | $8.36M | Sell |
|
|||||
|
2021
Q1 | $8.24M | Buy |
|
|||||
|
2020
Q4 | $9.11M | Sell |
|
|||||
|
2020
Q3 | $8.42M | Sell |
|
|||||
|
2020
Q2 | $9.61M | Buy |
|
|||||
|
2020
Q1 | $8.81M | Buy |
|
|||||
|
2019
Q4 | $11.3M | Buy |
|
|||||
|
2019
Q3 | $10.6M | Sell |
|
|||||
|
2019
Q2 | $11M | Sell |
|
|||||
|
2019
Q1 | $10.4M | Sell |
|
|||||
|
2018
Q4 | $8.71M | Buy |
|
|||||
|
2018
Q3 | $10.8M | Sell |
|
|||||
|
2018
Q2 | $12.1M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $3.87M | Buy |
|